Post-transplantation proteinuria and sirolimus [2]

New England Journal of Medicine

Volumn 353, Issue 19, 2005, Pages 2088-2089

  Izzedine, Hassane ^a   Brocheriou, Isabelle ^a   Frances, Camille ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; VASCULOTROPIN;

AGED; ALCOHOL LIVER CIRRHOSIS; ARTERY DISEASE; CASE REPORT; FOLLOW UP; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LETTER; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; NEPHROTOXICITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEINURIA; SKIN DEFECT; TREATMENT WITHDRAWAL;

EID: 27744569416     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM200511103531922     Document Type: Letter

References (5)

1. Stallone G, Schena A, Infante B, et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 2005;352:1317-23.
2. Morelon E, Kreis H. Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience. Transplant Proc 2003;35:Suppl:52S-57S.
3. Horita Y, Miyazaki M, Koji T, et al. Expression of vascular endothelial growth factor and its receptors in rats with protein-overload nephrosis. Nephrol Dial Transplant 1998;13:2519-28.
4. Laurinavicius A, Hurwitz S, Rennke HG. Collapsing glomerulopathy in HIV and non-HIV patients: a clinicopathological and follow-up study. Kidney Int 1999;56:2203-13.
5. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649-58.